NCT01275300View on ClinicalTrials.gov

Biosynthesis of PGD2 in Vivo

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Hyperlipidemia
Interventions
DRUG

Aspirin

DRUG

Placebo

DRUG

Niacin

Trial Locations (1)

19104

University of Pennsylvania Hospital, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01275300 - Biosynthesis of PGD2 in Vivo | Biotech Hunter | Biotech Hunter